These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21598613)

  • 1. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
    Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
    Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
    Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
    Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.
    Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S
    BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
    Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
    Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production and properties evaluation of monoclonal antibodies against Pseudomonas aeruginosa exotoxin A].
    Soldatenkova AV; Iakovleva IV; Gavrilova NV; Mikhaĭlova NA; Sviridova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):30-5. PubMed ID: 24738291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB
    Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract]   [Full Text] [Related]  

  • 9. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans.
    McEwan DL; Kirienko NV; Ausubel FM
    Cell Host Microbe; 2012 Apr; 11(4):364-74. PubMed ID: 22520464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudomonas aeruginosa recombinant proteins: effect on mice cytokine profile].
    Soldatenkova AV; Geĭderova LA; Akhmatova NK; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):80-7. PubMed ID: 24605680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codon optimization enhances secretory expression of Pseudomonas aeruginosa exotoxin A in E. coli.
    Wang X; Li X; Zhang Z; Shen X; Zhong F
    Protein Expr Purif; 2010 Jul; 72(1):101-6. PubMed ID: 20172029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.
    Jiang M; Yao J; Feng G
    PLoS One; 2014; 9(5):e96609. PubMed ID: 24788626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
    Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
    Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
    [No Abstract]   [Full Text] [Related]  

  • 15. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
    Cuccui J; Thomas RM; Moule MG; D'Elia RV; Laws TR; Mills DC; Williamson D; Atkins TP; Prior JL; Wren BW
    Open Biol; 2013 May; 3(5):130002. PubMed ID: 23697804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
    Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
    Fogle MR; Griswold JA; Oliver JW; Hamood AN
    J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE; Pastan I
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.